Zylox-Tonbridge Medical Technology Co., Ltd. (SEHK: 2190)
Health Care · Health Care Equipment & Supplies · CN
HK$19.36
-0.67% today · -18.3% 1Y
Zylox-Tonbridge Medical Technology Co., Ltd. (SEHK: 2190) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $817.55M and employs 925 people.
Over the last twelve months the share price has lost 18.3%, trading between 17.10 and 28.00.
Tweenvest scores Zylox-Tonbridge Medical Technology Co., Ltd. across four factors: quality 67/100, value 55/100, growth 100/100, dividend 43/100. Its strongest factor is growth.
2190 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $817.55M
- Revenue (TTM)
- $151.19M
- P/E
- 23.04
- EPS
- 0.76
- Dividend yield
- 1.32%
- Beta (5Y)
- 0.30
- 52-week high
- HK$28.00
- 52-week low
- HK$17.10
- Avg volume (3M)
- —
- Shares outstanding
- 331.39M
- Employees
- 925
- Next earnings
- —
About Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters for treating arterial stenoses or blockages in these same regions. Their neurovascular offerings further extend to Ton-Bridge extra soft coils, utilized for the endovascular embolization of intracranial aneurysms and other cerebral vascular malformations like arteriovenous malformations (AVMs) and fistulae. Supporting these are a range of microcatheters (for coiling or selective agent delivery), distal access and intracranial PTA balloon catheters, vascular snares, and IVC filter snare retrieval kits. Established in 2012, Zylox-Tonbridge Medical Technology Co., Ltd. maintains its headquarters in Zhejiang, People's Republic of China.
- ISIN
- CNE100004JD2
- Founded
- 2012
- Listed since
- Jul 5, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.67 | +0.03% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $373.57 | -1.38% |
| Stryker CorporationNYSE: SYK | $125.74B | $327.81 | -0.50% |
| Medtronic plcNYSE: MDT | $118.91B | $92.90 | -0.48% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €161.70 | -0.92% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.01 | -2.70% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €40.39 | +0.47% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.